The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy - EP3318255

The patent EP3318255 was granted to Amarin Pharmaceuticals Ireland on Mar 10, 2021. The application was filed on Jun 15, 2010 under application number EP17187534A. The patent is currently recorded with a legal status of "Revoked".

EP3318255

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP17187534A
Filing Date
Jun 15, 2010
Status
Revoked
Oct 21, 2022
Publication Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
COOKEDec 10, 2021ELKINGTON AND FIFEADMISSIBLE
HOFFMANN EITLEDec 8, 2021HOFFMANN EITLEADMISSIBLE
ELKINGTON AND FIFENov 24, 2021ELKINGTON AND FIFEADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONUS20071191467
OPPOSITIONUS2007191467
OPPOSITIONWO0044361
OPPOSITIONWO2008045465
SEARCHUS2007191467
SEARCHWO0044361
SEARCHWO2008045465

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents